Overview

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Status:
Terminated
Trial end date:
1999-03-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine whether intravenous immunoglobulin is an effective therapy for patients with mild or moderate myasthenia gravis.
Phase:
N/A
Details
Lead Sponsor:
University of Texas
Treatments:
Antibodies
gamma-Globulins
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin